Cookie Img
Back to top
Home » Products » Active Pharmaceutical Ingredients (API) » Voglibose


Product Code : 14
Brand Name : Voglibose
Product Description

Capitalizing on the proficiency of our professionals, we have been able to manufacture and export an unparalleled range of Voglibose. These drugs are prescribed for lowering post-prandial blood glucose levels in patients suffering with diabetes mellitus. Our Voglibose is processed from top quality ingredients at our state of the art machining facility, under the observation of veteran experts & pharmacists. We follow the parameters of the national and international quality standards to offer our clients with utmost pleasure in terms of quality.


  • High efficacy
  • No side effect
  • Pure quality

Further Details: 


 IUPAC Name : (1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol

CAS Number :83480-29-9

Innovator : It is a research product of Takeda Pharma, a Japan-based company.

Therapeutic Category:  Antidiabetics

Indication : Voglibose delays the absorption of glucose thereby reduces the risk of macrovascular complications

Dosage: Single dose of 0.2mg, given three times a day

Class: Diabeties


It is an alpha-glucosidase inhibitor 

Mechanism of Action:

Postprandial hyperglycemia (PPHG) is primarily due to first phase insulin secretion. Alpha glucosidase inhibitors delay glucose absorption at the intestine level and thereby prevent sudden surge of glucose after a meal.


Advog 0.2 mg  Eris Lifescience.

Voglase 0.2mg  Wockhardt Ltd.

Vobose 0.3mg  USV

Voglitab 0.3 mg  Intas Pharmaceuticals